false
Margaret Curnutte
Dr. Curnutte has more than ten years of research and regulatory affairs experience focused on in vitro diagnostics (IVDs). She has held regulatory positions at both device and pharmaceutical companies, during which she led seven U.S. and ex-U.S. companion diagnostic registrations. She has extensive expertise in CDx development and clinical trial integration, IVD product development, next-generation sequencing technologies, and translation of U.S. regulatory strategy to major markets.
-
Read: Companion Diagnostics: Key Considerations for Registrational Studies and Effective Co-Development with Therapeutics -
Read: Companion Diagnostics: Strategies for Biomarker Development and Early Phase Clinical Studies Companion Diagnostics: Strategies for Biomarker Development and Early Phase Clinical Studies
|
Loading...
You've reach the end